Mesh biocompatibility: effects of cellular inflammation and tissue remodelling
Tóm tắt
Từ khóa
Tài liệu tham khảo
Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V (2001) Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia 5:142–147
Lange B, Langer C, Markus PM, Becker H (2003) Mesh penetration of the sigmoid colon following a transabdominal preperitoneal hernia repair. Surg Endosc 17:157
Conze J, Rosch R, Klinge U, Weiss C, Anurov M, Titkowa S, Oettinger A, Schumpelick V (2004) Polypropylene in the intra-abdominal position: influence of pore size and surface area. Hernia 8:365–372
Conze J, Klinge U, Schumpelick V (2006) Evidenzbasierte laparoskopische Chirurgie - Narbenhernie. Viszeralchirurgie 41:246–252
Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382
Robinson TN, Clarke JH, Schoen J, Walsh MD (2005) Major mesh-related complications following hernia repair: events reported to the food and drug administration. Surg Endosc 19:1556–1560
Simons MP, Aufenacker T, Bay-Nielsen M, Bouillot JL, Campanelli G, Conze J, de Lange D, Fortelny R, Heikkinen T, Kingsnorth A, Kukleta J, Morales-Conde S, Nordin P, Schumpelick V, Smedberg S, Smietanski M, Weber G, Miserez M (2009) European Hernia society guidelines on the treatment of inguinal hernia in adult patients. Hernia 13:343–403
Usher F, JL O, Tuttle LJ (1958) Use of Marlex mesh in the repair of incisional hernias. Am Surg 24:969–974
Klinge U, Junge K, Stumpf M, AP AP, Klosterhalfen B (2002) Functional and morphological evaluation of a low-weight, monofilament polypropylene mesh for hernia repair. J Biomed Mater Res 63:129–136
Klinge U, Klosterhalfen B, Birkenhauer V, Junge K, Conze J, Schumpelick V (2002) Impact of polymer pore size on the interface scar formation in a rat model. J Surg Res 103:208–214
Klinge U, Klosterhalfen B, Conze J, Limberg W, Obolenski B, Ottinger AP, Schumpelick V (1998) Modified mesh for hernia repair that is adapted to the physiology of the abdominal wall. Eur J Surg 164:951–960
Horstmann R, Hellwig M, Classen C, Rottgermann S, Palmes D (2006) Impact of polypropylene amount on functional outcome and quality of life after inguinal hernia repair by the TAPP procedure using pure, mixed, and titanium-coated meshes. World J Surg 30:1742–1749
O'dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G (2005) Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 92:166–170
Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Heikkinen TJ (2006) Three-year results of a randomized clinical trial of lightweight or standard polypropylene mesh in Lichtenstein repair of primary inguinal hernia. Br J Surg 93:1056–1059
Nienhuijs S, Staal E, Strobbe L, Rosman C, Groenewoud H, Bleichrodt R (2007) Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J Surg 194:394–400
Conze J, Krones CJ, Schumpelick V, Klinge U (2007) Incisional hernia: challenge of re-operations after mesh repair. Langenbecks Arch Surg 392:453–457
Conze J, Binnebosel M, Junge K, Schumpelick V (2010) Incisional hernia—how do I do it? Standard surgical approach. Chirurg 81:192–200
Klinge U, Krones CJ (2005) Can we be sure that the meshes do improve the recurrence rates? Hernia 9:1–2
Nilsson B, Korsgren O, Lambris JD, Ekdahl KN (2010) Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Trends Immunol 31:32–38
Morais JM, Papadimitrakopoulos F, Burgess DJ (2010) Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J 12:188–196
Junge K, Rosch R, Klinge U, Krones C, Klosterhalfen B, Mertens PR, Lynen P, Kunz D, Preiss A, Peltroche-Llacsahuanga H, Schumpelick V (2005) Gentamicin supplementation of polyvinylidenfluoride mesh materials for infection prophylaxis. Biomaterials 26:787–793
Franz MG, Kuhn MA, Nguyen K, Wang X, Ko F, Wright TE, Robson MC (2001) Transforming growth factor beta(2) lowers the incidence of incisional hernias. J Surg Res 97:109–116
Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100
Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ (2005) Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 11:1–18
Jenney CR, Anderson JM (2000) Adsorbed IgG: a potent adhesive substrate for human macrophages. J Biomed Mater Res 50:281–290
Jenney CR, Anderson JM (2000) Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 49:435–447
Andersson J, Ekdahl KN, Larsson R, Nilsson UR, Nilsson B (2002) C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 168:5786–5791
Tengvall P, Askendal A, Lundstrom I (2001) I Ellipsometric in vitro studies on the activation of complement by human immunoglobulins M and G after adsorption to methylated silicon. Colloids Surf B Biointerfaces 20:51–62
Vroman L, Adams AL, Klings M (1971) Interactions among human blood proteins at interfaces. Fed Proc 30:1494–1502
Xu LC, Siedlecki CA (2007) Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. Biomaterials 28:3273–3283
Brash JL, Lyman DJ (1969) Adsorption of plasma proteins in solution to uncharged, hydrophobic polymer surfaces. J Biomed Mater Res 3:175–189
Krishnan A, Cha P, Liu YH, Allara D, Vogler EA (2006) Interfacial energetics of blood plasma and serum adsorption to a hydrophobic self-assembled monolayer surface. Biomaterials 27:3187–3194
Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) The role of complement in biomaterial-induced inflammation. Mol Immunol 44:82–94
Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25:5681–5703
Broughton G, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117:12S–34S
Rhodes NP, Hunt JA, Williams DF (1997) Macrophage subpopulation differentiation by stimulation with biomaterials. J Biomed Mater Res 37:481–8
Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610–621
Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ, Bornstein P (2004) The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165:2157–2166
Jones JA, Chang DT, Meyerson H, Colton E, Kwon IK, Matsuda T, Anderson JM (2007) Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 83:585–596
Esche C, Stellato C, Beck LA (2005) Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125:615–628
Brodbeck WG, Colton E, Anderson JM (2003) Effects of adsorbed heat labile serum proteins and fibrinogen on adhesion and apoptosis of monocytes/macrophages on biomaterials. J Mater Sci Mater Med 14:671–675
McNally AK, Anderson JM (1994) Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci USA 91:10119–10123
Gallant ND, Garcia AJ (2007) Model of integrin-mediated cell adhesion strengthening. J Biomech 40:1301–1309
McNally AK, Anderson JM (2002) Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 160:621–630
Rose DM, Alon R, Ginsberg MH (2007) Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev 218:126–134
Damsky CH, Ilic D (2002) Integrin signaling: it's where the action is. Curr Opin Cell Biol 14:594–602
Brodbeck WG, Patel J, Voskerician G, Christenson E, Shive MS, Nakayama Y, Matsuda T, Ziats NP, Anderson JM (2002) Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci USA 99:10287–10292
DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM (1997) Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 158:3385–3390
Helming L, Gordon S (2007) Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 37:33–42
Jones JA, Dadsetan M, Collier TO, Ebert M, Stokes KS, Ward RS, Hiltner PA, Anderson JM (2004) Macrophage behavior on surface-modified polyurethanes. J Biomater Sci Polym Ed 15:567–584
Henson PM (1971) The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol 107:1535–1546
Henson PM (1971) The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. J Immunol 107:1547–1557
Cozad MJ, Grant DA, Bachman SL, Grant DN, Ramshaw BJ, Grant SA (2010) Materials characterization of explanted polypropylene, polyethylene terephthalate, and expanded polytetrafluoroethylene composites: spectral and thermal analysis. J Biomed Mater Res B Appl Biomater 94:455–462
Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599–607
Li AG, Quinn MJ, Siddiqui Y, Wood MD, Federiuk IF, Duman HM, Ward WK (2007) Elevation of transforming growth factor beta (TGFbeta) and its downstream mediators in subcutaneous foreign body capsule tissue. J Biomed Mater Res A 82:498–508
Higgins DM, Basaraba RJ, Hohnbaum AC, Lee EJ, Grainger DW, Gonzalez-Juarrero M (2009) Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am J Pathol 175:161–170
Ward WK, Li AG, Siddiqui Y, Federiuk IF, Wang XJ (2008) Increased expression of Interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants. J Biomater Sci Polym Ed 19:1065–1072
Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163–176
Xue M, Le NT, Jackson CJ (2006) Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets 10:143–155
Le NT, Xue M, Castelnoble LA, Jackson CJ (2007) The dual personalities of matrix metalloproteinases in inflammation. Front Biosci 12:1475–1487
Ravi A, Garg P, Sitaraman SV (2007) Matrix metalloproteinases in inflammatory bowel disease: boon or a bane? Inflamm Bowel Dis 13:97–107
Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839
Jansen PL, Kever M, Rosch R, Krott E, Jansen M, Alfonso-Jaume A, Dooley S, Klinge U, Lovett DH, Mertens PR (2007) Polymeric meshes induce zonal regulation of matrix metalloproteinase-2 gene expression by macrophages and fibroblasts. FASEB J 21:1047–1057
Luttikhuizen DT, Harmsen MC, Van Luyn MJ (2006) Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12:1955–1970
Miller KM, Anderson JM (1989) In vitro stimulation of fibroblast activity by factors generated from human monocytes activated by biomedical polymers. J Biomed Mater Res 23:911–930
Miller KM, Rose-Caprara V, Anderson JM (1989) Generation of IL-1-like activity in response to biomedical polymer implants: a comparison of in vitro and in vivo models. J Biomed Mater Res 23:1007–1026
Junge K, Klinge U, Prescher A, Giboni P, Niewiera M, Schumpelick V (2001) Elasticity of the anterior abdominal wall and impact for reparation of incisional hernias using mesh implants. Hernia 5:113–118
Liebert TC, Chartoff RP, Cosgrove SL, McCuskey RS (1976) Subcutaneous implants of polypropylene filaments. J Biomed Mater Res 10:939–951
Mary C, Marois Y, King MW, Laroche G, Douville Y, Martin L, Guidoin R (1998) Comparison of the in vivo behavior of polyvinylidene fluoride and polypropylene sutures used in vascular surgery. ASAIO J 44:199–206
Vinard E, Eloy R, Descotes J, Brudon JR, Guidicelli H, Magne JL, Patra P, Berruet R, Huc A, Chauchard J (1988) Stability of performances of vascular prostheses retrospective study of 22 cases of human implanted prostheses. J Biomed Mater Res 22:633–648
Maarek JM, Guidoin R, Aubin M, Prud'homme RE (1984) Molecular weight characterization of virgin and explanted polyester arterial prostheses. J Biomed Mater Res 18:881–894
Berger K, Suavage L (1980) Late fiber deterioration in Dacron arterial grafts. Ann Surg 193:477–491
Riepe G, Loos J, Imig H, Schroder A, Schneider E, Petermann J, Rogge A, Ludwig M, Schenke A, Nassutt R, Chakfe N, Morlock M (1997) Long-term in vivo alterations of polyester vascular grafts in humans. Eur J Vasc Endovasc Surg 13:540–548
van der Lei B, Simmermacher RKJ, van Schilfgaarde R (1989) Expanded polytetrafluorethylene patch for the repair of large abdominal wall defects. Br J Surg 76:803–5
Bellon JM, Contreras LA, Bujan J (2000) Ultrastructural alterations of polytetrafluoroethylene prostheses implanted in abdominal wall provoked by infection: clinical and experimental study. World J Surg 24:528–531
Bellon JM, Contreras LA, Bujan J, Pascual G, Carrera-San Martin A (1999) Effect of relaparotomy through previously integrated polypropylene and polytetrafluoroethylene experimental implants in the abdominal wall. J Am Coll Surg 188:466–472
Klinge U, Klosterhalfen B, Ottinger AP, Junge K, Schumpelick V (2002) PVDF as a new polymer for the construction of surgical meshes. Biomaterials 23:3487–3493
Urban E, King MW, Guidoin R, Laroche G, Marois Y, Martin L, Cardou A, Douville Y (1994) Why make monofilament sutures out of polyvinylidene fluoride? ASAIO J 40:145–156
Conze J, Junge K, Weiss C, Anurov M, Oettinger A, Klinge U, Schumpelick V (2008) New polymer for intra-abdominal meshes–PVDF copolymer. J Biomed Mater Res B Appl Biomater 87:321–328
Junge K, Binnebosel M, Rosch R, Jansen M, Kammer D, Otto J, Schumpelick V, Klinge U (2009) Adhesion formation of a polyvinylidenfluoride/polypropylene mesh for intra-abdominal placement in a rodent animal model. Surg Endosc 23:327–333
Klosterhalfen B, Junge K, Klinge U (2005) The lightweight and large porous mesh concept for hernia repair. Expert Rev Med Devices 2:103–117
Weyhe D, Schmitz I, Belyaev O, Grabs R, Muller KM, Uhl W, Zumtobel V (2006) Experimental comparison of monofile light and heavy polypropylene meshes: less weight does not mean less biological response. World J Surg 30:1586–1591
Weyhe D, Belyaev O, Muller C, Meurer K, Bauer KH, Papapostolou G, Uhl W (2007) Improving outcomes in hernia repair by the use of light meshes–a comparison of different implant constructions based on a critical appraisal of the literature. World J Surg 31:234–244
Bellon JM, Jurado F, Garcia-Honduvilla N, Lopez R, Carrera-San Martin A, Bujan J (2002) The structure of a biomaterial rather than its chemical composition modulates the repair process at the peritoneal level. Am J Surg 184:154–159
Muhl T, Binnebosel M, Klinge U, Goedderz T (2008) New objective measurement to characterize the porosity of textile implants. J Biomed Mater Res B Appl Biomater 84:176–183
Eichhorn SJ, Sampson WW (2005) Statistical geometry of pores and statistics of porous nanofibrous assemblies. J R Soc Interface 2:309–318
Clowes AW, Zacharias RK, Kirkman TR (1987) Early endothelial coverage of synthetic arterial grafts: porosity revisited. Am J Surg 153:501–504
Tsukada H, Osada H (2004) Experimental study of a new tracheal prosthesis: pored Dacron tube. J Thorac Cardiovasc Surg 127:877–884
Frosch KH, Barvencik F, Lohmann CH, Viereck V, Siggelkow H, Breme J, Dresing K, Sturmer KM (2002) Migration, matrix production and lamellar bone formation of human osteoblast-like cells in porous titanium implants. Cells Tissues Organs 170:214–227
Zhang Y, Xu HH, Takagi S, Chow LC (2006) In-situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci Mater Med 17:437–445
Karageorgiou V, Kaplan D (2005) Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26:5474–5491
Cooper JA, Lu HH, Ko FK, Freeman JW, Laurencin CT (2005) Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation. Biomaterials 26:1523–1532
Bobyn JD, Stackpool GJ, Hacking SA, Tanzer M, Krygier JJ (1999) Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg Br 81:907–914
Ayers RA, Simske SJ, Nunes CR, Wolford LM (1998) Long-term bone ingrowth and residual microhardness of porous block hydroxyapatite implants in humans. J Oral Maxillofac Surg 56:1297–1301
Eggli PS, Muller W, Schenk RK (1988) Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. Clin Orthop Relat Res 127–138
Deng X, Guidoin R (2000) Alternative blood conduits: assessment of whether the porosity of synthetic prostheses is the key to long-term biofunctionality. Med Biol Eng Comput 38:219–225
Bragdon CR, Burke D, Lowenstein JD, O'Connor DO, Ramamurti B, Jasty M, Harris WH (1996) Differences in stiffness of the interface between a cementless porous implant and cancellous bone in vivo in dogs due to varying amounts of implant motion. J Arthroplasty 11:945–951
Zellin G, Linde A (1996) Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials 17:695–702
Bertheville B (2006) Porous single-phase NiTi processed under Ca reducing vapor for use as a bone graft substitute. Biomaterials 27:1246–1250
Martakos P, Karwoski T (1995) Healing characteristics of hybrid and conventional polytetrafluoroethylene vascular grafts. ASAIO J 41:M735–M741
Akers DL, Du YH, Kempczinski RF (1993) The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study. J Vasc Surg 18:10–15
Saberski ER, Orenstein SB, Novitsky YW (2010) Anisotropic evaluation of synthetic surgical meshes. Hernia
Binnebosel M, Rosch R, Junge K, Flanagan TC, Schwab R, Schumpelick V, Klinge U (2007) Biomechanical analyses of overlap and mesh dislocation in an incisional hernia model in vitro. Surgery 142:365–371
Klinge U, Junge K, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V (2002) Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacteria adherence, and the in vivo consequences in a rat model. J Biomed Mater Res 63:765–771
Engelsman AF, van Dam GM, van der Mei HC, Busscher HJ, Ploeg RJ (2010) In vivo evaluation of bacterial infection involving morphologically different surgical meshes. Ann Surg 251:133–137
Junge K, Klinge U, Rosch R, Klosterhalfen B, Schumpelick V (2002) Functional and morphologic properties of a modified mesh for Inguinal hernia repair. World J Surg 26:1472–1480
Rosch R, Junge K, Quester R, Klinge U, Klosterhalfen B, Schumpelick V (2003) Vypro II mesh in hernia repair: impact of polyglactin on long-term incorporation in rats. Eur Surg Res 35:445–450
Bellon JM, Rodriguez M, Garcia-Honduvilla N, Gomez-Gil V, Pascual G, Bujan J (2008) Postimplant behavior of lightweight polypropylene meshes in an experimental model of abdominal hernia. J Invest Surg 21:280–287
Bellon JM, Rodriguez M, Garcia-Honduvilla N, Pascual G, Bujan J (2007) Partially absorbable meshes for hernia repair offer advantages over nonabsorbable meshes. Am J Surg 194:68–74
Weyhe D, Belyaev O, Buettner G, Mros K, Mueller C, Meurer K, Papapostolou G, Uhl W (2008) In vitro comparison of three different mesh constructions. ANZ J Surg 78:55–60
Junge K, Rosch R, Krones CJ, Klinge U, Mertens PR, Lynen P, Schumpelick V, Klosterhalfen B (2005) Influence of polyglecaprone 25 (Monocryl) supplementation on the biocompatibility of a polypropylene mesh for hernia repair. Hernia 9:212–217
Otto J, Binnebosel M, Pietsch S, Anurov M, Titkova S, Ottinger AP, Jansen M, Rosch R, Kammer D, Klinge U (2010) Large-pore PDS mesh compared to small-pore PG mesh. J Invest Surg 23:190–196
Gruber-Blum S, Petter-Puchner AH, Brand J, Fortelny RH, Walder N, Oehlinger W, Koenig F, Redl H (2010) Comparison of three separate antiadhesive barriers for intraperitoneal onlay mesh hernia repair in an experimental model. Br J Surg
Loury JN, Chevrel JP (1983) Treatment of ventral hernias. Simultaneous use of polyglactin 910 and dacron mesh (letter). Presse Méd 12(2116 issn):0755–4982
Vries Reilingh TS, van Goor H, Koppe MJ, Bodegom ME, Hendriks T, Bleichrodt RP (2007) Interposition of polyglactin mesh does not prevent adhesion formation between viscera and polypropylene mesh. J Surg Res 140:27–30
Conze J, Junge K, Klinge U, Weiss C, Polivoda M, Oettinger AP, Schumpelick V (2005) Intraabdominal adhesion formation of polypropylene mesh. Influence of coverage of omentum and polyglactin. Surg Endosc 19:798–803
Bellon JM, Rodriguez M, Garcia-Honduvilla N, Pascual G, Gomez GV, Bujan J (2007) Peritoneal effects of prosthetic meshes used to repair abdominal wall defects: monitoring adhesions by sequential laparoscopy. J Laparoendosc Adv Surg Tech A 1:160–166
Jacob BP, Hogle NJ, Durak E, Kim T, Fowler DL (2007) Tissue ingrowth and bowel adhesion formation in an animal comparative study: polypropylene versus proceed versus parietex composite. Surg Endosc 21:629–633
Judge TW, Parker DM, Dinsmore RC (2007) Abdominal wall hernia repair: a comparison of sepramesh and parietex composite mesh in a rabbit hernia model. J Am Coll Surg 204:276–281
Emans PJ, Schreinemacher MH, Gijbels MJ, Beets GL, Greve JW, Koole LH, Bouvy ND (2009) Polypropylene meshes to prevent abdominal herniation. Can stable coatings prevent adhesions in the long term? Ann Biomed Eng 37:410–418
Schreinemacher MH, Emans PJ, Gijbels MJ, Greve JW, Beets GL, Bouvy ND (2009) Degradation of mesh coatings and intraperitoneal adhesion formation in an experimental model. Br J Surg 96:305–313
van't RM, de Vos van Steenwijk PJ, Bonthuis F, Marquet RL, Steyerberg EW, Jeekel J, Bonjer HJ (2003) Prevention of adhesion to prosthetic mesh: comparison of different barriers using an incisional hernia model. Ann Surg 237:123–128
Vrijland WW, Bonthuis F, Steyerberg EW, Marquet RL, Jeekel J, Bonjer HJ (2000) Peritoneal adhesions to prosthetic materials: choice of mesh for incisional hernia repair. Surg Endosc 14:960–963
Burger JW, Halm JA, Wijsmuller AR, ten Raa S, Jeekel J (2006) Evaluation of new prosthetic meshes for ventral hernia repair. Surg Endosc 20:1320–1325
Chelala E, Debardemaeker Y, Elias B, Charara F, Dessily M, Alle JL (2010) Eighty-five redo surgeries after 733 laparoscopic treatments for ventral and incisional hernia: adhesion and recurrence analysis. Hernia 14:123–129
Wassenaar EB, Schoenmaeckers EJ, Raymakers JT, Rakic S (2010) Subsequent abdominal surgery after laparoscopic ventral and incisional hernia repair with an expanded polytetrafluoroethylene mesh: a single institution experience with 72 reoperations. Hernia 14:137–142
Zinther NB, Zeuten A, Marinovskij E, Haislund M, Friis-Andersen H (2010) Functional cine MRI and transabdominal ultrasonography for the assessment of adhesions to implanted synthetic mesh 5–7 years after laparoscopic ventral hernia repair. Hernia 14:499–504
Jenkins ED, Yom V, Melman L, Brunt LM, Eagon JC, Frisella MM, Matthews BD (2010) Prospective evaluation of adhesion characteristics to intraperitoneal mesh and adhesiolysis-related complications during laparoscopic re-exploration after prior ventral hernia repair. Surg Endosc 24:3002–3007
Shastri VP (2003) Non-degradable biocompatible polymers in medicine: past, present and future. Curr Pharm Biotechnol 4:331–337
Wisniewski N, Reichert M (2000) Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces 18:197–219
Shen M, Horbett TA (2001) The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 57:336–345
de Vos P, van Hoogmoed CG, de Haan BJ, Busscher HJ (2002) Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J Biomed Mater Res 62:430–437
de Vos P, Hoogmoed CG, Busscher HJ (2002) Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells. J Biomed Mater Res 60:252–259
Vercruysse KP, Prestwich GD (1998) Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 15:513–555
Uchegbu IF, Schatzlein AG, Tetley L, Gray AI, Sludden J, Siddique S, Mosha E (1998) Polymeric chitosan-based vesicles for drug delivery. J Pharm Pharmacol 50:453–458
Borchard G, Junginger HE (2001) Modern drug delivery applications of chitosan. Adv Drug Deliv Rev 52:103
Sano A, Hojo T, Maeda M, Fujioka K (1998) Protein release from collagen matrices. Adv Drug Deliv Rev 31:247–266
Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55:1613–1629
Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, De Reu B, Schacht E (1998) In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 19:1677–1687
Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, Bogdanov B, Schacht E (1998) In vitro release characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 19:99–107
Athanasiou KA, Niederauer GG, Agrawal CM (1996) Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17:93–102
Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS (1995) Applications of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 12:475–95
Shive MS, Anderson JM (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5–24
Espadas-Torre C, Meyerhoff ME (1995) Thrombogenic properties of untreated and poly(ethylene oxide)-modified polymeric matrices useful for preparing intraarterial ion-selective electrodes. Anal Chem 67:3108–3114
Paradossi G, Cavalieri F, Chiessi E, Spagnoli C, Cowman MK (2003) Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications. J Mater Sci Mater Med 14:687–691
Maruoka S, Matsuura T, Kawasaki K, Okamoto M, Yoshiaki H, Kodama M, Sugiyama M, Annaka M (2006) Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 31:599–606
Voskerician G, Jin J, White MF, Williams CP, Rosen MJ (2010) Effect of biomaterial design criteria on the performance of surgical meshes for abdominal hernia repair: a pre-clinical evaluation in a chronic rat model. J Mater Sci Mater Med 21:1989–1995
Schug-Pass C, Sommerer F, Tannapfel A, Lippert H, Kockerling F (2009) The use of composite meshes in laparoscopic repair of abdominal wall hernias: are there differences in biocompatibily?: experimental results obtained in a laparoscopic porcine model. Surg Endosc 23:487–495
Murphy JL, Vollenweider L, Xu F, Lee BP (2010) Adhesive performance of biomimetic adhesive-coated biologic scaffolds. Biomacromolecules
Junge K, Rosch R, Anurov M, Titkova S, Ottinger A, Klinge U, Schumpelick V (2006) Modification of collagen formation using supplemented mesh materials. Hernia 10:492–497
Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–82
Kumar S (1999) Chronic groin sepsis following tension-free inguinal hernioplasty [letter; comment]. Br J Surg 86:1482
White TJ, Santos MC, Thompson JS (1998) Factors affecting wound complications in repair of ventral hernias. Am Surg 64:276–80
Deysine M (1998) Pathophysiology, prevention, and management of prosthetic infections in hernia surgery. Surg Clin North Am 78:1105–15
Taylor EW, Byrne DJ, Leaper DJ, Karran SJ, Browne MK, Mitchell KJ (1997) Antibiotic prophylaxis and open groin hernia repair. World J Surg 21:811–814
Rios A, Rodriguez JM, Munitiz V, Alcaraz P, Perez FD, Parrilla P (2001) Antibiotic prophylaxis in incisional hernia repair using a prosthesis. Hernia 5:148–152
Lazorthes F, Chiotasso P, Massip P, Materre JP, Sarkissian M (1992) Local antibiotic prophylaxis in inguinal hernia repair. Surg Gynecol Obstet 175:569–570
Musella M, Guido A, Musella S (2001) Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg 167:130–132
Pratesi C, Russo D, Dorigo W, Chiti E (2001) Antibiotic prophylaxis in clean surgery: vascular surgery. J Chemother 13(Spec No 1):123–128
McQueen MM, Hughes SP, May P, Verity L (1990) Cefuroxime in total joint arthroplasty. Intravenous or in bone cement. J Arthroplasty 5:169–172
Gilbert AI, Felton LL (1993) Infection in inguinal hernia repair considering biomaterials and antibiotics [published erratum appears in Surg Gynecol Obstet 1993 Nov;177(5):528]. Surg Gynecol Obstet 177:126–130
Badiou W, Lavigne JP, Bousquet PJ, O'Callaghan D, Mares P, de Tayrac R (2010) In vitro and in vivo assessment of silver-coated polypropylene mesh to prevent infection in a rat model. Int Urogynecol J Pelvic Floor Dysfunct
Franklin ME Jr, Gonzalez JJ Jr, Michaelson RP, Glass JL, Chock DA (2002) Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields. Hernia 6:171–174
Dubay DA, Wang X, Kuhn MA, Robson MC, Franz MG (2004) The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg 240:179–186
Robson MC, Dubay DA, Wang X, Franz MG (2004) Effect of cytokine growth factors on the prevention of acute wound failure. Wound Repair Regen 12:38–43
Korenkov M, Yuecel N, Koebke J, Schierholz J, Morsczeck C, Tasci I, Neugebauer EA, Nagelschmidt M (2005) Local administration of TGF-beta1 to reinforce the anterior abdominal wall in a rat model of incisional hernia. Hernia
Orenstein SB, Saberski ER, Klueh U, Kreutzer DL, Novitsky YW (2010) Effects of mast cell modulation on early host response to implanted synthetic meshes. Hernia 14:511–516
Tang L, Jennings TA, Eaton JW (1998) Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci USA 95:8841–8846
Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH (2005) Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 18:335–350
Schaffer M, Bongartz M, Hoffmann W, Viebahn R (2006) Regulation of nitric oxide synthesis in wounds by IFN-gamma depends on TNF-alpha. J Invest Surg 19:371–379
Park JY, Pillinger MH (2007) Interleukin-6 in the pathogenesis of rheumatoid arthritis. Bull NYU Hosp Jt Dis 65(Suppl 1):S4–10
Mudter J, Neurath MF (2007) Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 13:1016–1023
Di Vita G, D'Agostino P, Patti R, Arcara M, Caruso G, Davi V, Cillari E (2005) Acute inflammatory response after inguinal and incisional hernia repair with implantation of polypropylene mesh of different size. Langenbecks Arch Surg 390:306–311
Junge K, Binnebosel M, Rosch R, Otto J, Kammer D, Schumpelick V, Klinge U (2009) Impact of proinflammatory cytokine knockout on mesh integration. J Invest Surg 22:256–262
Junge K, Klinge U, Rosch R, Lynen P, Binnebosel M, Conze J, Mertens PR, Schwab R, Schumpelick, V (2007) Improved collagen type I/III ratio at the interface of gentamicin-supplemented polyvinylidenfluoride mesh materials. Langenbecks Arch Surg
Binnebosel M, Ricken C, Klink CD, Junge K, Jansen M, Schumpelick V, Lynen JP (2010) Impact of gentamicin-supplemented polyvinylidenfluoride mesh materials on MMP-2 expression and tissue integration in a transgenic mice model. Langenbecks Arch Surg 395:413–420
Tekos A, Prodromaki E, Papadimou E, Pavlidou D, Tsambaos D, Drainas D (2003) Aminoglycosides suppress tRNA processing in human epidermal keratinocytes in vitro. Skin Pharmacol Appl Skin Physiol 16:252–258
Sacha PT, Zaremba ML, Jakoniuk P (1999) The influence of antibiotics on phagocytic and bacteriocidal activity of rabbit peritoneal macrophages stimulated by filtrates of cultured t-lymphocytes. Med Dosw Mikrobiol 51:399–412
Keeling KM, Bedwell DM (2002) Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80:367–376
Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E (2003) Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349:1433–1441
Clancy JP, Bebok Z, Ruiz F, King C, Jones J, Walker L, Greer H, Hong J, Wing L, Macaluso M, Lyrene R, Sorscher EJ, Bedwell DM (2001) Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163:1683–1692
Wrzesniok D, Buszman E, Karna E, Nawrat P, Palka J (2002) Melanin potentiates gentamicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Eur J Pharmacol 446:7–13